Michael V. Seiden, M.D., Ph.D., is a physician and healthcare executive with a broad collection of leadership positions across the healthcare ecosystem. Currently, Dr. Seiden serves as the Chief Medical Officer of N Power Medicine, an innovative platform company that empowers community oncology practices to strengthen their culture of research.
Prior to joining N Power Medicine, he held numerous roles including serving as the President of The US Oncology Network, a McKesson owned company. Prior to serving as President of the network, Seiden served as the senior vice president and Chief Medical Officer of US Oncology and McKesson Specialty Health. Before joining McKesson, he served as CEO, President and Cancer Center Director of Fox Chase Cancer Center, a National Cancer Institute-designated Comprehensive Cancer Center. Prior to his time at Fox Chase Cancer Center, he held a variety of leadership roles at Massachusetts General Hospital (MGH) and Dana Farber Cancer Institute including the Director of the Clinical and Translational Research Programs at MGH Cancer Center and the leader of the Gynecologic Oncology Program at the Dana Farber/Harvard Cancer Center.
Dr. Seiden also serves on the Board of Medicom Technology, the Damon Runyon Cancer Research Foundation, and the Friends of Cancer Care for Tanzania.
Dr. Seiden received his undergraduate degree in Chemistry from Oberlin College and a master, medical and Ph.D. degrees from Washington University. He completed his residency at Massachusetts General Hospital (MGH), fellowships in medical oncology and bone marrow transplant at Dana Farber Cancer Institute, with post-doctoral fellowship training in molecular pathology at Brigham and Women’s Hospital.
